Announcements Trials
Browse Landscape

Phase

Phase 2 3

Status

Unknown 1Not yet recruiting 1Completed 1

Sponsor Class

OTHER 2OTHER_GOV 1

Study Type

Interventional 3

Sponsor

Cancer Type

Breast 9Thoracic 3Head & Neck 3Gynecologic 3Gastrointestinal 3Tumor-Agnostic 2Plasma cell 1Other hematologic neoplasm 1Other 1Myeloid 1Lymphoid 1Genitourinary 1Classical hematology 1CNS 1

Conditions

SCLC, Limited Stage 1Lung Neoplasms 1Carcinoma, Non-Small-Cell Lung 1

Interventions

Carboplatin 1145Cisplatin 874Pemetrexed 832pembrolizumab 604Paclitaxel 597Docetaxel 535Gemcitabine 424Radiotherapy 374Erlotinib Hydrochloride 367Nivolumab 322Bevacizumab 322Etoposide 294durvalumab 254Drug Therapy 233osimertinib 217atezolizumab 207Radiosurgery 188Gefitinib 177Vinorelbine 145130-nm albumin-bound paclitaxel 123Magnetic Resonance Spectroscopy 120Ipilimumab 118Cetuximab 113anlotinib 104tislelizumab 103Topotecan 101Cyclophosphamide 101Taxes 99Irinotecan 95Albumin-Bound Paclitaxel 92

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Interventional × Population Groups × Thoracic × Clear all
NCT07559786 2026-04-30

A Multicenter, Randomized, Cohort, Prospective Clinical Study of Adebrelimab Consolidation Therapy for Limited-Stage Small-Cell Lung Cancer (LS-SCLC) Without Progression After Concurrent Chemoradiotherapy

Henan Cancer Hospital

Phase 2 Not yet recruiting
200 enrolled
Thoracic

SCLC, Limited Stage

NCT01048762 2015-10-22

Multidisciplinary Rehabilitation After Cancer Pulmonis Operation

Aalborg University Hospital

Phase 2 Completed
78 enrolled
Thoracic

Lung Neoplasms

NCT01749072 2012-12-13

Vinorelbine-ifosfamide Versus Gefitinib for EGFR Gene Mutation Negative Non-small Cell Lung Cancer Patients

Peking Union Medical College Hospital

Phase 2 Unknown
120 enrolled
Thoracic

Carcinoma, Non-Small-Cell Lung

Data powered by HemOnc (CC BY 4.0) Colophon âš¡